Embecta Corp. (EMBC)
USD 12.73
(3.66%)
USD 12.73
(3.66%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 749.9 Million USD | -3.23% |
| 2022 | 774.9 Million USD | -3.14% |
| 2021 | 800 Million USD | 4.9% |
| 2020 | 762.6 Million USD | -2.98% |
| 2019 | 786 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 187.9 Million USD | 3.2% |
| 2024 Q1 | 185.9 Million USD | 2.26% |
| 2024 Q2 | 184.2 Million USD | -0.91% |
| 2023 Q4 | 181.8 Million USD | -4.06% |
| 2023 FY | 749.9 Million USD | -3.23% |
| 2023 Q3 | 189.5 Million USD | -0.16% |
| 2023 Q2 | 189.8 Million USD | 0.53% |
| 2023 Q1 | 188.8 Million USD | 6.73% |
| 2022 Q1 | 203.9 Million USD | -2.81% |
| 2022 FY | 774.9 Million USD | -3.14% |
| 2022 Q4 | 176.9 Million USD | -12.81% |
| 2022 Q3 | 202.9 Million USD | 6.12% |
| 2022 Q2 | 191.2 Million USD | -6.23% |
| 2021 Q1 | 191.3 Million USD | 0.0% |
| 2021 Q4 | 209.8 Million USD | 3.55% |
| 2021 Q3 | 202.6 Million USD | 3.21% |
| 2021 FY | 800 Million USD | 4.9% |
| 2021 Q2 | 196.3 Million USD | 2.61% |
| 2020 FY | 762.6 Million USD | -2.98% |
| 2019 FY | 786 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| ANI Pharmaceuticals, Inc. | 305.3 Million USD | -145.625% |
| Aquestive Therapeutics, Inc. | 29.75 Million USD | -2420.503% |
| Collegium Pharmaceutical, Inc. | 326.16 Million USD | -129.911% |
| Cosmos Health Inc. | 4.34 Million USD | -17140.789% |
| Cyclo Therapeutics, Inc. | -2.41 Million USD | 31213.91% |
| Esperion Therapeutics, Inc. | 73.06 Million USD | -926.318% |
| Cronos Group Inc. | 6.99 Million USD | -10626.808% |
| Incannex Healthcare Limited | 12 Thousand USD | -6249066.667% |
| Kala Pharmaceuticals, Inc. | -303 Thousand USD | 247591.749% |
| Lifecore Biomedical, Inc. | 41.85 Million USD | -1691.876% |
| Regencell Bioscience Holdings Limited | -745.58 Thousand USD | 100678.335% |
| Sunshine Biopharma, Inc. | 8.33 Million USD | -8892.501% |
| Sunshine Biopharma, Inc. | 8.33 Million USD | -8892.501% |
| SCYNEXIS, Inc. | 124.51 Million USD | -502.247% |
| Safety Shot Inc | -74.45 Thousand USD | 1007258.494% |
| Theratechnologies Inc. | 62.12 Million USD | -1107.005% |
| Alpha Teknova, Inc. | 10.29 Million USD | -7183.411% |
| Universe Pharmaceuticals INC | 10.07 Million USD | -7341.049% |
| Pacira BioSciences, Inc. | 490.3 Million USD | -52.944% |
| Sonoma Pharmaceuticals, Inc. | 4.74 Million USD | -15704.004% |
| Dynavax Technologies Corporation | 182.11 Million USD | -311.768% |
| Ironwood Pharmaceuticals, Inc. | 441.16 Million USD | -69.984% |
| Radius Health, Inc. | 307.71 Million USD | -143.703% |
| China SXT Pharmaceuticals, Inc. | 553.97 Thousand USD | -135268.097% |
| Alvotech | -69.42 Million USD | 1180.205% |
| Intra-Cellular Therapies, Inc. | 430.62 Million USD | -74.142% |
| SIGA Technologies, Inc. | 122.09 Million USD | -514.208% |
| Shineco, Inc. | 882.16 Thousand USD | -84906.484% |
| Silver Spike Investment Corp. | 8.1 Million USD | -9155.055% |
| Journey Medical Corporation | 52.52 Million USD | -1327.81% |
| Petros Pharmaceuticals, Inc. | 4.19 Million USD | -17792.387% |
| Harrow Health, Inc. | 90.55 Million USD | -728.134% |
| Procaps Group, S.A. | 239.56 Million USD | -213.02% |
| Biofrontera Inc. | 16.62 Million USD | -4410.134% |
| DURECT Corporation | 6.83 Million USD | -10877.895% |
| PainReform Ltd. | -15 Thousand USD | 4999433.333% |
| Supernus Pharmaceuticals, Inc. | 523.74 Million USD | -43.181% |
| OptiNose, Inc. | 62.35 Million USD | -1102.649% |
| RedHill Biopharma Ltd. | 3.05 Million USD | -24453.292% |
| Organogenesis Holdings Inc. | 309.79 Million USD | -142.067% |
| Cumberland Pharmaceuticals Inc. | 33.48 Million USD | -2139.45% |
| ProPhase Labs, Inc. | 16.23 Million USD | -4517.895% |
| Phibro Animal Health Corporation | 312.48 Million USD | -139.978% |
| Procaps Group S.A. | 239.56 Million USD | -213.02% |
| TherapeuticsMD, Inc. | 1.3 Million USD | -57496.006% |
| Viatris Inc. | 6.43 Billion USD | 88.353% |
| Rockwell Medical, Inc. | 8.7 Million USD | -8515.579% |
| Aytu BioPharma, Inc. | 54.58 Million USD | -1273.795% |
| Tilray Brands, Inc. | 223.35 Million USD | -235.75% |
| PetIQ, Inc. | 252.74 Million USD | -196.708% |
| Talphera, Inc. | -4.89 Million USD | 15419.714% |
| Neurocrine Biosciences, Inc. | 1.84 Billion USD | 59.408% |
| Alimera Sciences, Inc. | 61.17 Million USD | -1125.928% |
| Assertio Holdings, Inc. | 125.04 Million USD | -499.685% |
| Shuttle Pharmaceuticals Holdings, Inc. | -6811.00 USD | 11010230.671% |
| Avadel Pharmaceuticals plc | 27.11 Million USD | -2665.424% |
| Hempacco Co., Inc. | -1.21 Million USD | 61777.878% |
| Alvotech | -69.42 Million USD | 1180.205% |
| Lantheus Holdings, Inc. | 709.54 Million USD | -5.688% |
| Kamada Ltd. | 52.59 Million USD | -1325.862% |
| Currenc Group, Inc. | 17.35 Million USD | -4220.62% |
| Indivior PLC | 907 Million USD | 17.321% |
| Evoke Pharma, Inc. | 4.97 Million USD | -14962.011% |
| Flora Growth Corp. | 17.73 Million USD | -4127.647% |
| Cyclo Therapeutics, Inc. | -2.41 Million USD | 31213.91% |
| Evolus, Inc. | 140.52 Million USD | -433.638% |
| HUTCHMED (China) Limited | 453.55 Million USD | -65.339% |
| Amphastar Pharmaceuticals, Inc. | 343.96 Million USD | -118.014% |
| Akanda Corp. | 111.44 Thousand USD | -672763.821% |